Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
Clinical trial NCT00750841 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00750841
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-09
- Primary completion
- 2009-07-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.